{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:08:34Z","timestamp":1791461314138,"version":"4.3.4"},"reference-count":39,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"abstract":"<jats:p>Diet-induced obesity is reported to induce a phenotypic switch in adipose tissue macrophages from an antiinflammatory M2 state to a proinflammatory M1 state. Telmisartan, an angiotensin II type 1 receptor blocker and a peroxisome proliferator-activated receptor-\u03b3 agonist, reportedly has more beneficial effects on insulin sensitivity than other angiotensin II type 1 receptor blockers. In this study, we studied the effects of telmisartan on the adipose tissue macrophage phenotype in high-fat-fed mice. Telmisartan was administered for 5 wk to high-fat-fed C57BL\/6 mice. Insulin sensitivity, macrophage infiltration, and the gene expressions of M1 and M2 markers in visceral adipose tissues were then examined. An insulin- or a glucose-tolerance test showed that telmisartan treatment improved insulin resistance, decreasing the body weight gain, visceral fat weight, and adipocyte size without affecting the amount of energy intake. Telmisartan reduced the mRNA expression of CD11c and TNF-\u03b1, M1 macrophage markers, and significantly increased the expressions of M2 markers, such as CD163, CD209, and macrophage galactose N-acetyl-galactosamine specific lectin (Mgl2), in a quantitative RT-PCR analysis. A flow cytometry analysis showed that telmisartan decreased the number of M1 macrophages in visceral adipose tissues. In conclusion, telmisartan improves insulin sensitivity and modulates adipose tissue macrophage polarization to an antiinflammatory M2 state in high-fat-fed mice.<\/jats:p>","DOI":"10.1210\/en.2010-1312","type":"journal-article","created":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T02:33:08Z","timestamp":1300847588000},"page":"1789-1799","source":"Crossref","is-referenced-by-count":94,"title":["Telmisartan Improves Insulin Resistance and Modulates Adipose Tissue Macrophage Polarization in High-Fat-Fed Mice"],"prefix":"10.1210","volume":"152","author":[{"given":"Shiho","family":"Fujisaka","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Usui","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kanatani","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ikutani","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Takasaki","sequence":"first","affiliation":[{"name":"Division of Molecular Genetics Research (I.T., Y.T.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"first","affiliation":[{"name":"Life Science Research Center, Department of Diagnostic Pathology (K.Ts.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tabuchi","sequence":"first","affiliation":[{"name":"Division of Molecular Genetics Research (I.T., Y.T.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agussalim","family":"Bukhari","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamazaki","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikari","family":"Suzuki","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Senda","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminuddin","family":"Aminuddin","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Nagai","sequence":"first","affiliation":[{"name":"Department of Immunobiology and Pharmacological Genetics (M.I., Y.N., K.Ta.), Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Takatsu","sequence":"first","affiliation":[{"name":"Department of Immunobiology and Pharmacological Genetics (M.I., Y.N., K.Ta.), Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kobayashi","sequence":"first","affiliation":[{"name":"University Hospital (M.K.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Tobe","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine (S.F., I.U., Y.K., A.B., Y.Y., H.S., S.S., A.A., K.To.), University of Toyama, 930-0194 Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2011,3,22]]},"reference":[{"key":"2020071612525534500_B1","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance.","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders.","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"2020071612525534500_B3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI10842","article-title":"Obesity and insulin resistance.","volume":"106","author":"Kahn","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(01)00240-9","article-title":"Obesity and the regulation of energy balance.","volume":"104","author":"Spiegelman","year":"2001","journal-title":"Cell"},{"key":"2020071612525534500_B5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-\u03b1: direct role in obesity-linked insulin resistance.","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"2020071612525534500_B6","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue.","volume":"112","author":"Wellen","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B7","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1172\/JCI119752","article-title":"Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin\/angiotensin II crosstalk.","volume":"100","author":"Folli","year":"1997","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.HYP.0000111136.86976.26","article-title":"Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance.","volume":"43","author":"Shinozaki","year":"2004","journal-title":"Hypertension"},{"key":"2020071612525534500_B9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/diabetes.54.4.991","article-title":"Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance.","volume":"54","author":"Yvan-Charvet","year":"2005","journal-title":"Diabetes"},{"key":"2020071612525534500_B10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0026-0495(98)90355-9","article-title":"Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.","volume":"47","author":"Dal Ponte","year":"1998","journal-title":"Metabolism"},{"key":"2020071612525534500_B11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/hy1101.092970","article-title":"Selective angiotensin II receptor receptor antagonism reduces insulin resistance in obese Zucker rats.","volume":"38","author":"Henriksen","year":"2001","journal-title":"Hypertension"},{"key":"2020071612525534500_B12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00500383","article-title":"ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.","volume":"34","author":"Torlone","year":"1991","journal-title":"Diabetologia"},{"key":"2020071612525534500_B13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2337\/diacare.28.2.498","article-title":"Possible beneficial effect of telmisartan on glycemic control in diabetic subjects.","volume":"28","author":"Honjo","year":"2005","journal-title":"Diabetes Care"},{"key":"2020071612525534500_B14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2337\/diacare.28.3.757","article-title":"Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences.","volume":"28","author":"Miura","year":"2005","journal-title":"Diabetes Care"},{"key":"2020071612525534500_B15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diabres.2006.11.014","article-title":"Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.","volume":"77","author":"Usui","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2020071612525534500_B16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2840-4-6","article-title":"Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome.","volume":"4","author":"Vitale","year":"2005","journal-title":"Cardiovasc Diabetol"},{"key":"2020071612525534500_B17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR\u03b3-modulating activity.","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"2020071612525534500_B18","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-\u03b3 activity.","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"2020071612525534500_B19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/HYPERTENSIONAHA.107.086900","article-title":"Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies.","volume":"49","author":"Pravenec","year":"2007","journal-title":"Hypertension"},{"key":"2020071612525534500_B20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.HYP.0000225402.69580.1d","article-title":"Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice.","volume":"48","author":"Araki","year":"2006","journal-title":"Hypertension"},{"key":"2020071612525534500_B21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/01.HYP.0000215181.60228.f7","article-title":"Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.","volume":"47","author":"Sugimoto","year":"2006","journal-title":"Hypertension"},{"key":"2020071612525534500_B22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.amjhyper.2006.09.016","article-title":"Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.","volume":"20","author":"Mori","year":"2007","journal-title":"Am J Hypertens"},{"key":"2020071612525534500_B23","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.2337\/diabetes.54.12.3442","article-title":"Molecular characterization of new selective peroxisome proliferator-activated receptor \u03b3 modulators with angiotensin receptor blocking activity.","volume":"54","author":"Schupp","year":"2005","journal-title":"Diabetes"},{"key":"2020071612525534500_B24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0092-8674(02)01169-8","article-title":"SRC-1 and TIF2 control energy balance between white and brown adipose tissues.","volume":"111","author":"Picard","year":"2002","journal-title":"Cell"},{"key":"2020071612525534500_B25","doi-asserted-by":"crossref","first-page":"26602","DOI":"10.1074\/jbc.M601284200","article-title":"Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.","volume":"281","author":"Kamei","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071612525534500_B26","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding.","volume":"116","author":"Weisberg","year":"2006","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B28","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B29","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue.","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages.","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"2020071612525534500_B31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity.","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2020071612525534500_B32","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.2337\/db08-1475","article-title":"Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice.","volume":"58","author":"Fujisaka","year":"2009","journal-title":"Diabetes"},{"key":"2020071612525534500_B33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization.","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Invest"},{"key":"2020071612525534500_B34","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.","volume":"46","author":"Cinti","year":"2005","journal-title":"J Lipid Res"},{"key":"2020071612525534500_B35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cmet.2007.07.006","article-title":"Macrophage polarization and insulin resistance: PPAR\u03b3 in control.","volume":"6","author":"Charo","year":"2007","journal-title":"Cell Metab"},{"key":"2020071612525534500_B36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPAR\u03b3 controls alternative activation and improves insulin resistance.","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"2020071612525534500_B37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPAR\u03b3 activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metab"},{"key":"2020071612525534500_B38","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.54.7.1958","article-title":"Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5\u2032-phosphatase 2) on insulin signaling and glucose metabolism in mice.","volume":"54","author":"Fukui","year":"2005","journal-title":"Diabetes"},{"key":"2020071612525534500_B39","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI1235","article-title":"Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.","volume":"101","author":"Okuno","year":"1998","journal-title":"J Clin Invest"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/152\/5\/1789\/9035584\/endo1789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/152\/5\/1789\/9035584\/endo1789.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T22:14:36Z","timestamp":1594937676000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/152\/5\/1789\/2457085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,22]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2010-1312","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,22]]}}}